1. Oettgen HF, Old LJ, Boyse EA, Campbell HA, Philips FS, Clarkson BD et al. Inhibition of leukemias in man by L-asparaginase. Cancer Res 1967; 27: 2619–2631.
2. Jaffe N, Traggis D, Das L, Moloney WC, Hann HW, Kim BS et al. L-asparaginase in the treatment of neoplastic diseases in children. Cancer Res 1971; 31: 942–949.
3. Sutow WW, Garcia F, Starling KA, Williams TE, Lane DM, Gehan EA . L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group. Cancer 1971; 28: 819–824.
4. Tallal L, Tan C, Oettgen H, Wollner N, McCarthy M, Helson L et al. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer 1970; 25: 306–320.
5. Zwaan CM, Kaspers GJ, Pieters R, Ramakers-Van Woerden NL, den Boer ML, Wunsche R et al. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood 2000; 96: 2879–2886.